ArticleLeukemia2026
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.
Abstract readLetter
In one paragraph
Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Riccardo Moia *Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy. riccardo.moia@uniupo.it.ORCID http://orcid.org/0000-0001-7393-1138
Simone Ragaini *Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0003-3899-5755
Luciano CascioneInstitute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland.
Andrea RinaldiInstitute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland.
Elisa GenuardiHematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Donatella TalottaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy.ORCID http://orcid.org/0009-0004-5875-8508
Mohammad AlmasriDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy.ORCID http://orcid.org/0000-0002-0048-3845
Alessio BruscagginInstitute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland.
Gian Maria ZaccariaDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari, Italy.ORCID http://orcid.org/0000-0001-5643-5917
Andrea EvangelistaUnit of Cancer Epidemiology, CPO Piemonte, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
Aurora Maria CivitaHematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Alice Di RoccoDepartment of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy.
Luigi PetrucciDepartment of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy.
Federica CavalloHematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0003-2047-1099
Melania CelliHematology Unit, Ospedale degli Infermi, Rimini, Italy.
Mario LuppiAzienda Ospedaliero Universitaria di Modena Policlinico, Ematologia, Modena, Italy.
Caterina StelitanoGrande Ospedale Metropolitano, Bianchi Melacrino Morelli, Ematologia Reggio Calabria, Reggio Calabria, Italy.
Piero Maria StefaniHematology Unit, Department of Medicine, Treviso General Hospital, Treviso, Italy.
Carlo ViscoDepartment of Engineering for Innovative Medicine, University of Verona, Verona, Italy.
Atto BillioDivision of Hematology and BMT, General Hospital of Bolzano, Bolzano, Italy.
Ivana CasaroliHaematology Department, San Gerardo Hospital Monza, Monza, Italy.
Claudia CastellinoDepartment of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy.
Enzo PavoneCard.G.Panico Hospital, Tricase (Lecce), Italy.
Sara GalimbertiSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID http://orcid.org/0000-0002-4620-0038
Caterina PlentedaHematology and BMT Unit, Ospedale Maggiore, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Francesco MerliAzienda USL-IRCCS of Reggio Emilia, Department of Hematology, Reggio Emilia, Italy.
Abdurraouf Mokhtar MahmoudDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy.
Davide RossiInstitute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy.ORCID http://orcid.org/0000-0002-4681-0151
Marco LadettoDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara, Italy.
Francesco BertoniInstitute of Oncology Research (IOR), Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland.ORCID http://orcid.org/0000-0001-5637-8983
Simone FerreroHematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0002-9711-1502
Funding
Associazione Italiana Contro le Leucemie - Linfomi e Mieloma (Associazione Italiana Contro le Leucemie - Linfomi e Mieloma ONLUS) AIL Novara VCOAssociazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 5x1000, grant N 21198Krebsliga Schweiz (Ligue Suisse Contre le Cancer) KLS-3636-02-2015Leukemia and Lymphoma Society (Leukemia & Lymphoma Society) MCL 7005-24Ministero della Salute (Ministry of Health, Italy) RF-2021-12371972
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.